Thymoquinone Promotes Pancreatic Cancer Cell Death and Reduction of Tumor Size through Combined Inhibition of Histone Deacetylation and Induction of Histone Acetylation.
Publication/Presentation Date
1-1-2016
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is virtually therapy-resistant. As noninvasive lesions progress to malignancy, the precursor period provides a window for cancer therapies that can interfere with neoplastic progression. Thymoquinone (Tq), a major bioactive component of essential oil from
Volume
2016
First Page
1407840
Last Page
1407840
ISSN
2090-3480
Published In/Presented At
Relles, D., Chipitsyna, G. I., Gong, Q., Yeo, C. J., & Arafat, H. A. (2016). Thymoquinone Promotes Pancreatic Cancer Cell Death and Reduction of Tumor Size through Combined Inhibition of Histone Deacetylation and Induction of Histone Acetylation. Advances In Preventive Medicine, 2016, 1407840. https://doi.org/10.1155/2016/1407
Disciplines
Surgery
PubMedID
28105374
Department(s)
Department of Surgery, Department of Surgery Faculty
Document Type
Article
COinS